ALT 5 Sigma Inc.
Through New Partnership Firms Will Offer a "White Label" Mobile App, OTC Platform, Trading Desk and Visa/Mastercard Branded Solution to the Bitcoin Industry.
NEW YORK, NY / ACCESSWIRE / December 23, 2021 / ALT 5 Sigma Inc., a global fintech that provides next generation blockchain powered technologies for the trading, clearing, settlement, payment, and insured custodianship of digital instruments, announced today it has formed an exclusive partnership with BankLine, the only crypto-friendly banking solution that offers a portfolio of redundant depository institutions willing to serve the varied needs of the crypto industry.
Through the partnership, ALT 5 Sigma will provide its flagship products, ALT 5 Prime Enterprise, ALT 5 Liquidity and ALT 5 Pay. ALT 5 Prime Enterprise is a complete "white label crypto exchange" with best price execution and a branded Visa/ Mastercard designed to enhance user experience and increase customer retention. ALT 5 Liquidity offers the Bitcoin ATM Industry to ability to receive best price execution either through an OTC Desk and or through a complete integration via FIX APIs, whereas the ALT 5 Pay service enables the integration of crypto payment and all three services are available in a branded "white label" deployment.
"We look forward to working with the exciting team at BankLine and their customers at creating more efficient and innovative products in the ever-changing land of digital assets," said Richard Groome, ALT 5 Sigma's Executive Chairman.
Alt 5 Sigma and BankLine are a perfect fit," said Mark Ochab, President and CEO of BankLine. "BankLine is focused on delivering innovative technologies, banking, and related services to the BTM industry. The ALT 5 Sigma platform will allow our BTM customers to transform from a single purpose cash-based kiosk into a full-service exchange, delivering a comprehensive suite of services and payment options to their customers."
The Visa and Mastercard programs enable banks and other institutions using ALT 5 Sigma's trading platform to offer branded Visa and/or Mastercard credit cards to their registered end users which are linked to their digital assets' accounts. ALT 5 Prime clients will be able to use the cards at any retailer globally that accepts the cards as payments, as well as any ATMs globally.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ALT 5 Sigma
ALT 5 Sigma is a global fintech that provides next generation blockchain powered technologies for the trading, clearing, settlement, payment, and insured custodianship of digital instruments. ALT 5 was founded by financial industry specialists out of the necessity to provide the digital asset economy with security, accessibility, transparency, and compliance. ALT 5 provides its clients the ability to buy, sell and hold digital assets in a safe and secure environment deployed with the best practices of the financial industry. ALT 5 Sigma's products and services are available to Banks, Broker Dealers, Funds, Family Offices, Professional Traders, Retail Traders, Digital Asset Exchanges, Digital Asset Brokers, Blockchain Developers, and Financial Information Providers. ALT 5's digital asset custodian services are secured by Fireblocks.
Learn more at alt5sigma.com or connect on LinkedIn or Twitter.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About BankLine
BankLine is the only Crypto-friendly banking solution that offers a portfolio of redundant financial institutions willing to serve the varied needs of the Crypto industry. BankLine's network of Crypto-friendly banks and services helps mitigate the threat of bank discontinuance and provides ongoing, sustainable and scalable banking and support services.
Each BankLine customer has a direct relationship at a FDIC insured depository institution. The accounts are titled in the business entity's name and are exclusive for the entity's activity.
BankLine's BTM clients have access to full-service banking solutions at a FDIC insured financial institution, contracting more than 250 Loomis, Brinks, and Garda Cash Vault facilities, servicing well over 25,000 BTM locations across the USA and its territories.
BankLine is now expanding Crypto-friendly banking and armored cash logistics services to the EU, UK, as well as Central and South America.
Learn more at bankline.com
CONTACT:
ScottK@calibercorporateadvisers.com
(917) 647-1810
SOURCE: ALT 5 Sigma Inc.
View source version on accesswire.com:
https://www.accesswire.com/679266/ALT-5-Sigma-and-BankLine-Announce-Partnership-to-Bring-Digital-Asset-Platform-to-Bitcoin-ATMs
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
SK tes Launches New Circular IT Facility in Shannon, Expanding Ireland’s Role in Global Sustainable Tech Services24.4.2025 09:30:00 CEST | Press release
SHANNON, IE / ACCESS Newswire / April 24, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, has announced plans to open a new 36,000 square foot purpose-built facility in Shannon, marking a major vote of confidence in Ireland's thriving data and technology sector. The new facility will deliver comprehensive ITAD, data center decommissioning, and technology lifecycle management services to some of Ireland's largest enterprises, including hyperscale data center operators, while supporting national sustainability and circular economy goals. It will also create over 25 skilled jobs in one of the country's fastest-growing tech regions. "Ireland is at the forefront of Europe's digital economy, and our investment in Shannon reinforces our commitment to helping Irish companies manage technology securely, sustainably, and at scale," said Eric Ingebretsen, Chief Commercial Officer at SK tes. "This facility will allow us to meet the uniqu
Sauce Labs Launches Industry-First Enterprise Scale iOS 18 Testing on Sauce Labs Virtual Device Cloud, Boosting Test Speeds up to 40%24.4.2025 08:00:00 CEST | Press release
Leading test automation platform, powering development for over 300,000 active users and having executed more than 8 billion tests, enables developers and QA teams to ensure app quality on Apple's latest OS with unprecedented performance and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 24, 2025 / Sauce Labs Inc., the leading platform for continuous quality, trusted by dev teams around the world to deliver apps users love, today announced the general availability of iOS 18 testing on its Virtual Device Cloud (VDC). Leveraging its new, high-performance Apple Silicon cloud infrastructure, Sauce Labs offers the market's most scalable enterprise-ready solution for automated mobile app and web testing on iOS 17.5, iOS 18, and beyond, enabling teams to execute tests up to 40% faster compared to previous versions. This launch addresses the critical need for timely testing support driven by Apple's transition to its proprietary Apple Silicon architecture and the rapid adoption rate of new
Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare Disinfection24.4.2025 07:00:00 CEST | Press release
Delivering Effective Germ Control in Five Minutes BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in specialty chemicals and innovative solutions, announces the launch of NUGEN® HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution disinfects medical devices in just five minutes, ensuring that even the most resilient microorganisms, which can withstand harsh conditions, are destroyed.* NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating rooms, isolation areas, and intensive care units where speed and safety are essential. "We are excited to introduce NUGEN® HLD-CD to the healthcare market," said Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a game-changer in disinfection technology for healthcare facilities, providing professionals with a powerful means to improve patie
TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea
BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom